Page last updated: 2024-11-06

corticosterone and Basal Ganglia Diseases

corticosterone has been researched along with Basal Ganglia Diseases in 1 studies

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research Excerpts

ExcerptRelevanceReference
" dosing and its effects did not show tolerance on repeated dosing."1.28Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist. ( Christofferson, CL; Corbin, A; Demattos, S; DeWald, HA; Meltzer, LT; Myers, SL; Pugsley, TA; Shih, YH; Whetzel, SZ; Wiley, JN, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pugsley, TA1
Christofferson, CL1
Corbin, A1
DeWald, HA1
Demattos, S1
Meltzer, LT1
Myers, SL1
Shih, YH1
Whetzel, SZ1
Wiley, JN1

Other Studies

1 other study available for corticosterone and Basal Ganglia Diseases

ArticleYear
Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:3

    Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Cebus; Corticosterone; Coumarins; Do

1992